Search for: "United States v. Broadcast Music, Inc" Results 141 - 160 of 190
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Oct 2012, 8:19 am by Chris Castle
  Proponents of this fallacy (such as the sponsors of the IRFA bill) leave out the July 6, 2012 ruling of the United States Court of Appeals for the District of Columbia Circuit in Intercollegiate Broadcasting System Inc v. [read post]
18 May 2013, 5:30 am by Barry Sookman
Alice Corp http://t.co/4b9u2FKyC6 -> Is a broadcast to everyone private under the Copyright Act? [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360)   Global - Copyright Expanding the public domain: part zero (Creative Commons)     Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian… [read post]
13 Oct 2008, 12:12 pm
ECJ clarifies rules relating to notice: K-Swiss Inc v OHIM (Class 46) EU Competitiveness Council resolution against counterfeiting and piracy (Class 46) EU states back three-point anti-piracy plan (Managing Intellectual Property) Fuel cells and wind power lead European patent filings for clean energy technology (Green Patent Blog) More non-minor geographical indicator (GI) amendments published (Class 46) No sign of any Community patent progress, despite Verheugen's… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
21 Feb 2022, 12:24 am by INFORRM
United States Sarah Palin has lost her libel claim against the New York Times. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
6 Mar 2022, 4:02 pm by INFORRM
On 1 March 2022 Nicklin J heard an application in the case of SMO v Tik Tok Inc. [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas),… [read post]
16 Sep 2009, 1:47 pm
(Melrose, MA; Robert Atherton, President) Andover Community Music School, Inc. [read post]
15 Mar 2008, 7:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WIPO Copyright Committee 16th session to discuss Broadcast Treaty, new proposal for exceptions and limitations agreement: (Public Knowledge), (Public Knowledge), (Intellectual Property Watch), (Public Knowledge), (Public Knowledge), (IPwar’s), (Intellectual Property Watch), (KEI), (Public Knowledge), (IP Justice), (IP Justice), (KEI),… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]